關於 nucleai ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Nucleai to present data on multiplex immunofluorescence ...

Artificial intelligence firm Nucleai on Monday announced the expansion of its spatial biology platform to include a new generation of ...

#12. Nucleai - Headquarters Locations, Products, Competitors ...

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

#13. Nucleai company information, funding & investors - Dealroom.co

Nucleai, our mission, expertise, and passion are to improve cancer diagnostics. Here you'll find information about their funding, investors and team.

#14. Nucleai Hopes to Engage Pharma on Next-Gen ...

Nucleai Hopes to Engage Pharma on Next-Gen Immunotherapies With Proof-of-Concept AI-Based Biomarker ... However, the firm will pursue its spatial ...

#15. Nucleai Expands Scientific Advisory Board with Oncology ...

Nucleai Expands Scientific Advisory Board with Oncology Industry Luminary Dr. Julian Adams Business Wire TEL AVIV, Israel -- November 8, ...

#16. Nucleai, Propath UK partner to develop AI-backed immuno ...

Nucleai and Propath UK, a CRO in biopharmaceutical sector, have partnered to develop and validate a 30-plex immunofluorescence (IF) panel.

#17. Nucleai - Home - Facebook

Nucleai is Leading the Spatial Biology Revolution in Precision Medicine עין זיתים 4 תל אביב, ישראל, 67013 Tel Aviv, Israel.

#18. Debiopharm's portfolio company NucleAI

NucleAI's core technology analyzes large and unique datasets of tissue images using computer vision and machine learning methods to model the spatial ...

#19. Nucleai, Propath Partnership Paves Way for Spatial Oncology ...

Nucleai and Propath UK have announced a partnership to develop and validate an immunofluorescence assay focused on 30 immuno-oncology ...

#20. Propath UK, Nucleai Partner on Spatial Proteomics Panel for ...

NEW YORK – Contract research organization Propath UK and spatial biology informatics firm Nucleai said Wednesday that they have entered a ...

#21. Nucleai Archives - - Pharmaphorum

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its. Share. X. Sanofi backs precision oncology firm ...

#22. Nucleai - Email Address & Phone Number - Lusha

Nucleai. The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions.

#23. Nucleai - A Grove Ventures Portfolio Company

Nucleai leads the Spatial Biology revolution in precision medicine by improving the cancer diagnostics process and treatment.

#24. Nucleai | Tracxn

Nucleai About. Provider of AI-based image analysis solutions for researchers. The company is developing AI algorithms that inspect tissue biopsies using ...

#25. Nucleai Raises $33M in Series B Financing - FinSMEs

Nucleai, a Tel Aviv, Israel-based AI-powered spatial biology company, raised $33M in Series B funding. The round was led by Section 32 and ...

#26. NucleAI | impact1st Investments

NucleAI's solution also represents the next step in the evolution of cancer detection— NucleAI enables pathologists to save 50% of their diagnosis time and ...

#27. Lunaphore and Nucleai partner for AI-powered spatial biology ...

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in ...

#28. Nucleai - Dribbble

Nucleai. Inspirational designs, illustrations, and graphic elements from the world's best designers. Want more inspiration? Browse our search results.

#29. Nucleai - CipherBio

The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions. Nucleai's platform ...

#30. Nucleai company information, funding & investors

Nucleai, our mission, expertise, and passion are to improve cancer diagnostics. Here you'll find information about their funding, investors and team.

#31. Nucleai Launches New Multiplex Imaging ... - AiThority.com

Nucleai, AI-powered spatial biology, announced the expansion of its spatial biology platform to include a new generation of multiplex.

#32. Nucleai Appoints Dr. Julian Adams to Scientific Advisory Board

TEL AVIV, Israel–(BUSINESS WIRE)–Nucleai, an AI-powered spatial biology leader, announced that Dr. Julian Adams has joined its scientific ...

#33. Nucleai and Jefferson Health Launch a Strategic ...

On September 14, 2021 Nucleai, a leader in AI-powered spatial biology, and Jefferson Health, a leading cancer center, reported that they ...

#34. Nucleai Announces Partnership With Protean BioDiagnostics ...

Nucleai, a precision medicine AI company in the pathology domain, announced today its partnership with Protean BioDiagnostics, a Tampa-based ...

#35. Nucleai Secured $6.5M Series-A Initial Closing Led by ...

Nucleai's core technology analyzes large and unique datasets of tissue images using computer vision and machine learning methods to model the spatial ...

#36. Nucleai - Overview, News & Competitors | ZoomInfo.com

Nucleai is a leading provider of AI-powered precision oncology technology transforming biomarker discovery and treatment decisions.

#37. Nucleai Expands Scientific Advisory Board ... - PharmiWeb.com

TEL AVIV, Israel--(BUSINESS WIRE)--#aipowered--Nucleai, an AI-powered spatial biology leader, announced that Dr. Julian Adams has joined its ...

#38. Lunaphore and Nucleai announce a partnership to provide AI ...

“Nucleai brings innovative spatial biology and machine learning platform (ATOM) to empower researchers with novel insights into drug discovery,” ...

#39. Nucleai closes $33 million financing to advance spatial ...

Nucleai, an Israeli based AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions ...

#40. Nucleai Ltd. | Public Marketplace - Scientist

Nucleai is a leading AI company in the field of pathology, with an extensive pathology platform that allows for various applications.

#41. Merck KGaA and Nucleai to Develop Novel Biomarkers for ...

Nucleai and Merck KGaA collaborate utilizing Nucleai's AI-powered platform to develop pathology-based biomarkers as companion diagnostics.

#42. Nucleai | AI-powered Precision Oncology Platform, AI Startup ...

Nucleai is an AI-powered precision oncology platform that provides biomarker discovery and treatment decisions for cancer treatments.

#43. NUCLEAI AND DEBIOPHARM LAUNCH RESEARCH ...

Debiopharm International SA - Tel Aviv, Israel / Lausanne, Switzerland - Nucleai (www.Nucleaimd.com), a ...✚ Read more.

#44. AI-powered cancer-fighting machine Nucleai raises $6.5M

Nonetheless, Israeli startup Nucleai aims to harness the power of AI to better assist in the battle against cancer. It doesn't replace the ...

#45. Nucleai Archives - DATAVERSITY

Nucleai's experienced team has adapted artificial intelligence technology previously used for satellite image analysis to the detection of cancer using […].

#46. BiCroLab/nucleAI: Unsupervised machine learning of WSI

Unsupervised machine learning of WSI. Contribute to BiCroLab/nucleAI development by creating an account on GitHub.

#47. AI＋生物标志物｜Nucleai完成3300万美元B轮融资 - 腾讯网

Nucleai 将进一步利用人工智能和空间生物学，来寻找能够预测哪些患者将对癌症治疗产生反应的生物标志物。 融资由Section 32和Sanofi Ventures共同领导，现 ...

#48. AI bio-tech company Nucleai raises $33M, brings in new ...

Israeli bio-tech company Nucleai has closed a $33 million Series B financing round, jointly led by Section 32 and Sanofi Ventures.

#49. Nucleai, AI Spatial Biology Startup, Partners with US-Based ...

Israeli startup Nucleai, which is transforming drug development and clinical treatment, announced a partnership with the US-based contract ...

#50. Nucleai | Biotech Careers

Website: Nucleai. Business Area(s):. Artificial Intelligence · Clinical Imaging · Biopsy · Cancer Diagnostics. Description: Developing a technology platform ...

#51. This Israeli startup leverages AI to help pathologists handle ...

Avi Veidman was prompted to create the Tel Aviv-based company, Nucleai, after witnessing his father anxiously wait about 30 days to receive ...

#52. Nucleai Announces Participation in United States and ...

PRNewswire/ -- Nucleai, an AI company working with and for pathologists to improve diagnoses, announced it will be exhibiting at the 2019 ...

#53. Kenneth Bloom - 2023sv - PMWC Precision Medicine World ...

Nucleai. Kenneth J Bloom, MD, FCAP is the Head of Pathology at Nucleai. He brings more than 35 years of clinical experience in pathology, oncology, ...

#54. Nucleai - Pagan Research

Nucleai is a leading provider of an AI-powered precision oncology platform ... Nucleai was founded in 2017 by Avi Veidman, Eliron Amir and Lotan Chorev.

#55. Nucleai - Wiki - Golden

Nucleai is a Tel Aviv-based company that uses artificial intelligence to design and create solutions for the healthcare industry, specifically for cancer ...

#56. Nucleai and Merck Launch Translational Medicine Collaboration

Nucleai's platform analyzes tissue images using computer vision and machine learning methods to model the tumor and the immune system's spatial characteristics, ...

#57. ATOM AI-powered image analysis platform Nucleai MD (IL)

Nucleai MD. (6/24/21). "Press Release: Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai's AI-Powered ...

#58. 80_Nucleai.pdf - Kenes Exhibitions

Avi Veidman, Founder and CEO, Nucleai o Investment Rational. Nucleai is an AI healthcare company, in the pathology domain. Nucleai's platform.

#59. Israeli AI precision oncology co Nucleai raises $33m - Globes

Nucleai is an AI-powered spatial biology company, which seeks to transform drug development and clinical treatment decisions through ...

#60. Nucleai partners with Sirona Dx for AI-driven discovery of ...

The partnership combines Nucleai's AI spatial analytics platform with Sirona Dx's multiplex assay development expertise, to identify novel ...

#61. Nucleai raises $33M in Series B financing - Medical Buyer

Nucleai, an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking ...

#62. Nucleai Archives - ISRAEL21c

Nucleai. Medical records image by Metamorworks via Shutterstock.com. Innovation. February 11, 8:30 am. 10 Israeli companies scouring digital data to save ...

#63. AI Technology Stack Nucleai - StartupHub.ai

Machine learning and deep learning algorithms to find novel digital biomarkers that predict patients' response to new treatments. Our algorithms detect and ...

#64. Nucleai Ltd. - CMOCRO

Nucleai is a global provider of AI-powered pathology-based biomarker discovery that transforms the way pathology data is used throughout the research and ...

#65. Nuclei scores $33M for AI-enabled pathology platform and ...

Nucleai, maker of an AI-powered pathology platform that aims to predict a patient's response to treatment, announced Tuesday it had raised ...

#66. Nucleai and Merck KGaA Darmstadt ... - NTB Kommunikasjon

Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based ...

#67. CTech news, and updates about Nucleai

All CTech updates, news stories, and analysis about Nucleai on your mobile ... Nucleai raises $33 million for spatial biology drug development platform.

#68. Representation of Nucleai in Raising $33 Million during ...

Kobi Ben Chitrit, Liron Hacohen and Nitzan Fischer Conforti represented Nucleai in its raising of $33 million in Round B jointly led by ...

#69. total cross sections of light nucleai near the 3-3 resonance ...

Article. Title, A comparison ofπ+ and |pi− total cross sections of light nucleai near the 3-3 resonance. Author(s), Wilkin, C ; Cox, ...

#70. IL-NUCLEAI | Business Wire - Via Ritzau

Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai's AI-Powered Biomarker Platform.

#71. Nucleai - Studio Luka

Nucleai. Nucleai Offices. Architects: Gindi Studio & Yael Bekerman. Photography: Yoav Peled. Nucleai Big Image Logo Reflects In Hall.

#72. Nucleai and Debiopharm Launch Research Collaboration ...

Nucleai and Debiopharm Launch Research Collaboration Utilizing Nucleai's Ai-Powered Biomarker Platform - read this article along with other ...

#73. Nucleai and Merck KGaA Darmstadt ... - Calgary Herald

CHICAGO — Nucleai ( ... Germany Launch Translational Medicine Collaboration Utilizing Nucleai's AI-Powered Biomarker Platform.

#74. Nucleai raises $6.5m to advance predictive oncology platform

Computational biology startup Nucleai has raised $6.5m in funding to advance its AI platform used to make oncology treatment predictions.

#75. Meet Avi Veidman · CEO and Founder of Nucleai - YouTube

After remarking the shortcomings of biopsy analysis, including long wait times and inconsistencies, Avi Viedman, responded with a ...

#76. Nucleai - IATI - Israel Advanced Technology Industries

Nucleai. IATI (Israel Advanced Technology Industries) is Israel's umbrella organization of high-tech and life science industries. Our +700 members belong to ...

#77. Nucleai Partners with Protean BioDiagnostics to Improve ...

Nucleai Partners with Protean BioDiagnostics to Improve Cancer Diagnosis By CIOReview - Nucleai, a high-precision medicine artificial ...

#78. Nucleai lands $33m Series B - Venture Capital Journal

Nucleai, an AI-powered spatial biology company, has raised $33 million in Series B financing. Section 32 and Sanofi Ventures led the round.

#79. Protean BioDiagnostics to Launch HistoAI in Conjunction with ...

Protean BioDiagnostics has collaborated with Nucleai to create a new Artificial Intelligence based product, HistoAI, for improving the ...

#80. Nucleai announces partnership with Protean BioDiagnostics

Nucleai and Protean BioDiagnostics are launching a co-branded campaign, Protean QA Service Enhancement powered by Nucleai.

#81. Nucleai, Propath UK, immuno-oncology - Tissuepathology.com

Combining the power of spatial biology and AI, Propath and Nucleai push the boundaries of pathology tissue analytics to develop a novel, ...

#82. Lunaphore, Nucleai partner to provide AI-powered spatial ...

“Nucleai brings innovative spatial biology and machine learning platform (ATOM) to empower researchers with novel insights into drug discovery,” ...

#83. Nucleai Closes $33 Million Series B Financing to ... - BeBeez

Nucleai is working with most of the leading pharmaceutical companies to harness spatial biology for new drug development, clinical trials, and ...

#84. S2E7 - Digital Pathology Today

Nucleai is committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI- powered image analysis ...

#85. חברת Nucleai גייסה 33 מיליון דולר להצלת חולים אונקולוגיים - כלכליסט

Nucleai, הפועלת בתחום הביולוגיה החישובית, גייסה 33 מיליון דולר בסבב B. את הסבב הובילו Section32, קרן בעולם הרפואי שהוקמה על ידי ביל האריס ...

#86. Precipio and Nucleai Partner to Develop Artificial

(NASDAQ:PRPO), announced today an agreement with Israel-based artificial intelligence pathology platform company Nucleai who specializes in ...

#87. Nucleai and Jefferson Health Launch a Strategic ... - Via TT

Nucleai, a leader in AI-powered spatial biology, and Jefferson Health, a leading cancer center, announce that they have entered into a ...

#88. Nucleai, AI Cancer Detection Startup Raises $5m

Nucleai Ltd., a Tel Aviv-based startup, recently unveiled the close of its $5 million seed round. Israeli-based VC funds including Grove ...

#89. Nucleai and Debiopharm team up for cancer drug development

Nucleai will work with Debiopharm to optimize development of a clinical oncology asset per a new research collaboration.

#90. Nucleai (Israel) - Video

Nucleai aims to Improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by ...

#91. Nucleai - The Times of Israel

Nucleai's team: Lotan Chorev VP R&D, Eliron Amir, COO, Avi Veidman,. July 8, 2020, 12:52 pm. Nucleai raises $6.5 million to help pharma ...

#92. Sheba Hospital and Nucleai Partner Up to Create AI for Drug ...

Nucleai is a leading provider of AI-powered precision oncology platforms that leverage tissue datasets to produce insights that aid cancer biomarker analysis ...

#93. Highest paying jobs at Nucleai - Ladders

Find high paying available jobs at Nucleai.For expert network information on Nucleai compensation and careers, use Ladders $100K + Club.

#94. Nucleai - Information Technology & Services - Apollo.io

Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, ...

#95. Nucleai (Israel) - Video - AI Startups

Nucleai aims to Improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by ...

#96. “We need to optimize payer programs” with Avi Veidman, CEO ...

As a part of my interview series with leaders in healthcare, I had the pleasure to interview Avi Veidman, CEO and Founder of Nucleai.